Illumina sold genomic-sequencing systems with software vulnerabilities, leading to an FDA warning.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Illumina sold genomic-sequencing systems with software vulnerabilities, leading to an FDA warning.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Illumina
American company that develops systems for the analysis of genetic variation
Nothing else this week.
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
Coverage
Newest first; wire copies grouped- Cybersecurity DiveDOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims This story was originally published on Cybersecurity Dive. To receive daily news and insights, subscribe to our free